Healthtech startup Wellscare will be participating in CES 2022 by sharing a number of new products, including the IASO-Ultra self-therapy device for herniated disk patients. The compact wearable can be used anytime and anywhere for pain relief, and it takes the form of a hands-free unit that provides targeted support where it is needed most.
This self-treatment device for back pain has the potential to support a common cause of pain in many individuals, visual display terminals syndrome, or VDT. With increased smartphone and computer use, VDT syndrome patients are growing, and this wearable helps to address one of the many symptoms of extended device use.
Wellscare is also introducing other solutions at CES 2022 that provide different kinds of support for various activities.
Wearable Self-Therapy Devices
The IASO-Ultra for Herniated Disk Patients is Coming to CES 2022
Trend Themes
1. Wearable Self-therapy Devices - The IASO-Ultra self-therapy device for herniated disk patients has the potential to address one of the many symptoms of extended device use, VDT syndrome.
2. Targeted Pain Relief Wearables - The compact and hands-free design of the IASO-Ultra self-therapy device for herniated disk patients presents the opportunity for developing more targeted pain relief wearables.
3. Mobile Healthcare Devices - The IASO-Ultra self-therapy device for herniated disk patients shows the potential for further innovation in mobile healthcare devices.
Industry Implications
1. Healthtech - Wellscare's IASO-Ultra self-therapy device for herniated disk patients exemplifies the intersection of technology and healthcare, presenting opportunities for further innovation in the healthtech industry.
2. Wearable Technology - The IASO-Ultra self-therapy device for herniated disk patients represents a new application for wearable technology and presents opportunities for further development in the industry.
3. Computer and Smartphone Industry - With the growing use of computers and smartphones, the rise in VDT syndrome patients presents opportunities for device manufacturers to collaborate with healthcare companies to develop solutions such as Wellscare's IASO-Ultra self-therapy device.